Taysha Gene Therapies, Inc. (TSHA)
NASDAQ·Healthcare·Biotechnology
$5.76
+3.14%
Mkt Cap $1.35B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (15 analysts)
$11.80
Range $11.00 – $13.00
Implied Upside
+105.0%
Consensus $11.80 vs current $5.76
NASDAQ·Healthcare·Biotechnology
$5.76
+3.14%
Mkt Cap $1.35B
Buy
6
Hold
0
Sell
0
Price Target (15 analysts)
$11.80
Range $11.00 – $13.00
+105.0%
Consensus $11.80 vs current $5.76